What is Chrono-log?
Chrono-log operates at the intersection of biotechnology and clinical diagnostics, specializing in the design, development, and manufacturing of advanced platelet technologies. The company provides a comprehensive suite of aggregation systems, reagents, and laboratory supplies essential for the precise assessment of platelet function. By facilitating the diagnosis of platelet function defects and enabling the monitoring of anti-platelet drug efficacy, Chrono-log plays a critical role in modern healthcare. Their solutions are engineered to assist both clinical practitioners and research scientists in mitigating risks associated with thrombosis and bleeding disorders, ultimately driving improvements in patient outcomes and optimizing therapeutic protocols.
How much funding has Chrono-log raised?
Chrono-log has raised a total of $483K across 2 funding rounds:
Debt
$150K
Debt
$333K
Debt (2020): $150K with participation from PPP
Debt (2021): $333K led by PPP
Key Investors in Chrono-log
PPP
Public-Private Partnership
What's next for Chrono-log?
With this late-stage capital, Chrono-log is poised to scale its manufacturing infrastructure and deepen its market penetration. The strategic focus will likely shift toward enhancing the integration of their diagnostic systems within high-throughput clinical environments. As the demand for personalized medicine and precise anti-platelet therapy monitoring continues to rise, the company is strategically aligned to capitalize on these industry tailwinds. Future growth initiatives will likely prioritize the expansion of their reagent portfolio and the refinement of their proprietary testing methodologies to maintain a competitive edge in the diagnostic technology landscape.
See full Chrono-log company page
